Medical Research Commercialisation Fund IIF Overview

  • Fund Strategy
  • Venture

  • Fund Status
  • Closed

  • Size

  • Vintage
  • 2011

Vintage

  • Dry Powder

Medical Research Commercialisation Fund IIF General Information

Description

Medical Research Commercialisation Fund IIF is a venture capital fund co-managed by Brandon Biocatalyst and Brandon Capital. The fund is located in Melbourne, Australia.

Contact Information

Fund Category
Venture Capital
Close Date
Fund Family
Medical Research Commercialisation Fund
Medical Research Commercialisation Fund
Native Currency
AUD
Fund Manager's Location
  • Level 9
  • 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia
+61 (03)
Fund Domiciles
Australia

Medical Research Commercialisation Fund IIF Investments (8)

Medical Research Commercialisation Fund IIF has made a total of 8 investments. Its most recent deal was a with Vaxxas for . The deal was made on 09-Feb-2015.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Vaxxas 09-Feb-2015 Drug Delivery Clinical Trials - General
Vaxxas 09-Feb-2015 Drug Delivery Clinical Trials - General
Q-Sera 01-Jan-2015 Medical Supplies Generating Revenue
Heart Metabolics 17-Apr-2014 Diagnostic Equipment Generating Revenue
Q-Sera 18-Jun-2012 Medical Supplies Startup
GI Therapies 01-Mar-2012 Therapeutic Devices Generating Revenue
Vaxxas 01-Aug-2011 Early Stage VC (Series A) Drug Delivery Startup
Otifex Therapeutics 01-Dec-2010 Seed Round Drug Discovery Startup
To view Medical Research Commercialisation Fund IIF’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medical Research Commercialisation Fund IIF Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

Medical Research Commercialisation Fund IIF Limited Partners (2)

AustralianSuper is one of Medical Research Commercialisation Fund IIF’s 2 limited partners. Its latest Original was on 01-Jan-2011.

Limited Partner Name Type Status Commitment Date Commitment Type
AustralianSuper Current 01-Jan-2011 Original
Hostplus Superannuation Fund Union Pension Fund Current 01-Jan-2011 Original
To view Medical Research Commercialisation Fund IIF’s complete limited partners history, request access »

Medical Research Commercialisation Fund IIF Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

Medical Research Commercialisation Fund IIF Returns History

Period Contribution (by all LPs) Dry Powder Distribution (to all LPs) NAV Total Fund Distr+NAV IRR DPI RVPI TVPI Dry Powder %

This information is available in the PitchBook Platform. To explore Medical Research Commercialisation Fund IIF‘s full profile, request access.

Request a free trial

Medical Research Commercialisation Fund IIF Benchmark (8)

Fund Name Fund Type Vintage IRR Quartile As of Date
Glilot Capital Partners 30-Sep-2022
Jordan Growth Capital Fund
DGF Early Stage 1
Digital Accelerator
Digitalbusiness Portfolio III
Catalyst Investments III 30-Jun-2025
Pontifax Fund III
Business Partners International Rwanda SME Fund

Medical Research Commercialisation Fund IIF FAQs

  • What is Medical Research Commercialisation Fund IIF?

    Medical Research Commercialisation Fund IIF is a venture capital fund co-managed by Brandon Biocatalyst and Brandon Capital.

  • Who manages Medical Research Commercialisation Fund IIF?

    Medical Research Commercialisation Fund IIF is managed by Brandon Capital and Brandon Biocatalyst.

  • Where is Medical Research Commercialisation Fund IIF domiciled?

    Medical Research Commercialisation Fund IIF is domiciled in Australia.

  • What is Medical Research Commercialisation Fund IIF's size?

    Medical Research Commercialisation Fund IIF has a size of .

  • What type of fund is Medical Research Commercialisation Fund IIF?

    The fund type of Medical Research Commercialisation Fund IIF is Venture.

  • What is the status of Medical Research Commercialisation Fund IIF?

    Medical Research Commercialisation Fund IIF is closed.

  • What has Medical Research Commercialisation Fund IIF invested in?

    Medical Research Commercialisation Fund IIF has made numerous investments in companies like Vaxxas, Q-Sera, and Heart Metabolics within the Drug Delivery, Medical Supplies, and Diagnostic Equipment industries.

  • What has Medical Research Commercialisation Fund IIF invested in recently?

    Medical Research Commercialisation Fund IIF's latest investment was on 09-Feb-2015 in Vaxxas, a company within the Drug Delivery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process